Neurotrack is a digital health company dedicated to the development of non-invasive cognitive health assessment tools that will enable earlier and more effective evaluation of patients who may be at risk for cognitive decline, and help advance research of treatments for cognitive diseases, including Alzheimer's.
Neurotrack is on a mission to transform the measurement and management of cognition and memory loss
Neurotrack was founded in 2012 by Elli Kaplan, Stuart Zola, Elizabeth Buffalo, & Cecelia Manzanares and is based in Redwood City, California.
Neurotrack's Memory Health Program is an app-based, personalized digital therapy that supports behavioral change across multiple risk factors such as physical activity, nutrition, vascular health, and cognitive training, through on-demand health as well as coaching that can be accessed anywhere.
Neurotrack is building the digital memory health platform of the future, giving people direct access to digital tools and technology to assess, preserve, and strengthen their memory health.
Neurotrack's comprehensive platform helps people assess their memory through the company's proprietary Imprint™ cognitive assessment, and manage memory loss and cognitive decline with the help of Neurotrack's highly personalized digital therapeutic.
Neurotrack is backed by Khosla Ventures, Sozo Ventures, Dai-ichi Life, SOMPO holdings, Rethink Impact, AME Cloud Partners and Marc Benioff among others.